Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-018775

Chief Executive Officer acquired 84,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2024-05-28 Option exercise +84,000 $0.00 $84 250,130.8 D
Derivatives
Robinson Chandler Chief Executive Officer 2024-05-28 Option exercise · Stock Options −84,000 0 D
Loading xslF345X05/rdgdoc.xml…